Acadian Asset Management
COLL icon

Acadian Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Acadian Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,776
Closed -$83K – 2057
2025
Q4 		$83K Buy
+1,776
New +$74.3K ﹤0.01% 1720
2021
Q2 		– Sell
-1,067
Closed -$25K – 2028
2021
Q1 		$25K Sell
1,067
-5,554
-84% -$132K ﹤0.01% 1957
2020
Q4 		$133K Sell
6,621
-110,869
-94% -$2.16M ﹤0.01% 1665
2020
Q3 		$2.45M Sell
117,490
-143,320
-55% -$2.59M 0.01% 615
2020
Q2 		$4.56M Sell
260,810
-123,727
-32% -$2.42M 0.02% 507
2020
Q1 		$6.28M Buy
384,537
+129,695
+51% +$2.68M 0.04% 350
2019
Q4 		$5.24M Buy
254,842
+28,754
+13% +$479K 0.02% 427
2019
Q3 		$2.6M Buy
226,088
+9,557
+4% +$109K 0.01% 611
2019
Q2 		$2.85M Buy
216,531
+79,564
+58% +$1.06M 0.01% 521
2019
Q1 		$2.07M Buy
+136,967
New +$2.19M 0.01% 685
2018
Q1 		– Sell
-9,508
Closed -$176K – 1696
2017
Q4 		$176K Buy
+9,508
New +$136K ﹤0.01% 982

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Acadian Asset Management's COLL Position: Q1 2026 in Review

Acadian Asset Management sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 1,776 shares — an estimated $83K sold.

Acadian Asset Management first reported a position in COLL in Q4 2017 and held it in 11 quarters. The position peaked at $6.28M in Q1 2020. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Acadian Asset Management reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Acadian Asset Management sold 1,776 Collegium Pharmaceutical shares in Q1 2026, an estimated $83K.
  • Acadian Asset Management first reported a position in Collegium Pharmaceutical in Q4 2017 and held it in 11 quarters.
  • Acadian Asset Management's Collegium Pharmaceutical position peaked at $6.28M in Q1 2020.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.